Correlation Between VBI Vaccines and ADMA Biologics
Can any of the company-specific risk be diversified away by investing in both VBI Vaccines and ADMA Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VBI Vaccines and ADMA Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VBI Vaccines and ADMA Biologics, you can compare the effects of market volatilities on VBI Vaccines and ADMA Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VBI Vaccines with a short position of ADMA Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VBI Vaccines and ADMA Biologics.
Diversification Opportunities for VBI Vaccines and ADMA Biologics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between VBI and ADMA is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding VBI Vaccines and ADMA Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADMA Biologics and VBI Vaccines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VBI Vaccines are associated (or correlated) with ADMA Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADMA Biologics has no effect on the direction of VBI Vaccines i.e., VBI Vaccines and ADMA Biologics go up and down completely randomly.
Pair Corralation between VBI Vaccines and ADMA Biologics
If you would invest 1,789 in ADMA Biologics on December 26, 2024 and sell it today you would earn a total of 233.00 from holding ADMA Biologics or generate 13.02% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
VBI Vaccines vs. ADMA Biologics
Performance |
Timeline |
VBI Vaccines |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
ADMA Biologics |
VBI Vaccines and ADMA Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with VBI Vaccines and ADMA Biologics
The main advantage of trading using opposite VBI Vaccines and ADMA Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VBI Vaccines position performs unexpectedly, ADMA Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will offset losses from the drop in ADMA Biologics' long position.VBI Vaccines vs. Tonix Pharmaceuticals Holding | VBI Vaccines vs. Jaguar Animal Health | VBI Vaccines vs. Vaxart Inc | VBI Vaccines vs. Allogene Therapeutics |
ADMA Biologics vs. Atara Biotherapeutics | ADMA Biologics vs. Fate Therapeutics | ADMA Biologics vs. Sana Biotechnology | ADMA Biologics vs. Caribou Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |